A cross-sectional study was conducted. Faecal sampling was carried out from 2016 to 2018 and obtained from 350 patients with an HIV/AIDS positive status associated with diarrhoea attending inpatient (hospitalisation) and outpatient care units at El Hadi Flici (ex El- Kettar) hospital, Alger city, Algeria. After obtaining informed consent, patients completed a comprehensive questionnaire on age, sex, contact with animals (pets and farm animals) and drinking water sources. Clinical characteristics, including diarrhoea, weight loss, vomiting, abdominal pain and nausea, types of HAART drug regimens and laboratory characteristics, including blood CD4+ T-cell counts, were recorded by the physicians in charge. Cryptosporidium microscopy-based screening was performed in El Hadi Flici Ex El- Kettar hospital, Alger city, Algeria. All specimens were smeared onto glass slides, stained using the modified Ziehl Nielsen (mZN) and auramine techniques [15 (link)] and examined using light (1000×) and fluorescence (100× and 400×) microscopy, respectively (Figure 1). A sample was considered Cryptosporidium-positive if typical 4–6 μm diameter oocysts were visible. Positive samples were transferred to the Centre National de Référence–Laboratoire Expert crypyosporidioses (CNR-LE) (Rouen University Hospital, France) for molecular analysis.
Free full text: Click here